Ascension Life Fund

Stage

Seed-Seed+

Ticket Size

£150k-£400k

Round Size

£1m-£5m

Business Characteristics

The Ascension Life Fund invests into a portfolio of at least 8 high potential HealthTech and Life Science companies per year. It is a new specialist fund combining the sector expertise of the Investment Team with Ascension’s reputation, operational experience and track record.

Leads?

Can lead rounds or follow

The Ascension Life Fund has adopted an investment approach that focuses on four key elements of any potential business: the quality of the team, the strength of the intellectual property, the robustness of the technology vs. competition, and market size/potential of the product.

The focus is on UK HealthTech and Life Sciences companies raising Seed+ funding rounds that bridge the equity gap between Seed and Series A rounds.

EIS investing can offer favourable tax reliefs

Income Tax Relief of 30% on Amount Invested
100% Capital Gains Tax Deferral
Tax Free Capital Gains
Loss Relief
Inheritance Tax Relief

Next Closing Date

July 4th 2022

Request Brochure

Apply Online

More Info

The Ascension Life Fund’s industry and investment experience has led it to focus on four areas where it feels above average returns are achievable:

Healthcare Data & Platforms
BioTech
MedTech, incl. Medical Devices
Pharmaceutical Value Chain

The Fund’s competitive advantage is driven by an exceptional team of operators and network of advisors (20+), with extensive experience and expertise within the specific investment themes. The extended network has benefits throughout the investment life cycle from qualified deal origination and technical due diligence to post-investment support and follow-on funding.